|
English
|
正體中文
|
简体中文
|
2818748
|
|
???header.visitor??? :
28329382
???header.onlineuser??? :
1335
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"papp k"???jsp.browse.items-by-author.description???
Showing items 1-2 of 2 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 臺大學術典藏 |
2020-10-22T07:28:03Z |
Secukinumab in plaque psoriasis - Results of two phase 3 trials
|
Karpov A.; Hampele I.; Notter M.; Salko T.; Tyring S.; Langley R.G.; Elewski B.E.; Lebwohl M.; Reich K.; Griffiths C.E.M.; Papp K.; Puig L.; Nakagawa H.; Spelman L.; Sigurgeirsson B.; Rivas E.; TSEN-FANG TSAI; Wasel N.; Helou S.; Papavassilis C. |
| 國立臺灣大學 |
2014 |
Secukinumab in subjects with moderate-to-severe plaque psoriasis: Results from the Efficacy of Response and Safety of 2 fixed secUkinumab REgimens in psoriasis (ERASURE)
|
Elewski, B.; Lebwohl, M.; Papp, K.; Nakagawa, H.; Sigurgeirsson, B.; Tsai, T. -F.; Tyring, S.; Hampele, I.; Karpov, A.; Helou, S.; Papavassilis, C.; 蔡呈芳 |
Showing items 1-2 of 2 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
